Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CBRS
CBRS logo

CBRS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cerebras Systems Inc (CBRS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
199.460
1 Day change
-12.02%
52 Week Range
--
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Cerebras Systems Inc (CBRS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has shown strong momentum since its IPO, with a 68% surge on its first trading day and a 9.85% increase in the regular market. Its innovative AI chip technology and significant revenue growth (75% last year) make it a promising long-term investment despite operational losses and client concentration risks.

Technical Analysis

The stock is showing strong upward momentum, with a 9.85% increase in the regular market and a 2.97% pre-market gain. This indicates strong investor interest and bullish sentiment.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
0
Buy
0

Positive Catalysts

  • Cerebras' Wafer-Scale Engine chip is larger and faster than Nvidia's leading chip, showcasing its potential in the AI computing market.

  • The stock surged 68% on its first trading day, reflecting strong investor optimism.

  • Revenue grew 75% last year, reaching $509 million.

Neutral/Negative Catalysts

  • Operational loss of $145 million last year.

  • A significant portion of revenue comes from a small number of clients, posing a risk to growth.

Financial Performance

Cerebras reported a 75% increase in revenue last year, reaching $509 million, despite an operational loss of $145 million. The upcoming earnings report on June 23, 2026, will provide further insights.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for trend analysis or analyst ratings. However, the stock's strong debut and innovative product position it favorably in the AI chip market.

Wall Street analysts forecast CBRS stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast CBRS stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 226.720
sliders
Low
0
Averages
0
High
0
0
Current: 226.720
sliders
Low
0
Averages
0
High
0
Wedbush
Outperform
maintain
$270 -> $280
AI Analysis
2026-06-24
New
Reason
Wedbush
Price Target
$270 -> $280
AI Analysis
2026-06-24
New
maintain
Outperform
Reason
Wedbush raised the firm's price target on Cerebras Systems to $280 from $270 and keeps an Outperform rating on the shares. Cerebras reported results ahead of initial expectations with no major surprises, while ongoing engagements with large customers support a constructive outlook, the analyst tells investors in a research note.
UBS
Buy
maintain
$300 -> $320
2026-06-24
New
Reason
UBS
Price Target
$300 -> $320
2026-06-24
New
maintain
Buy
Reason
UBS raised the firm's price target on Cerebras Systems (CBRS) to $320 from $300 and keeps a Buy rating on the shares. Cerebras's first post-IPO earnings call is viewed positively after raised guidance and confirmation of an Amazon (AMZN) agreement, and broader customer diversification and accelerating demand for specialized infrastructure could support strong growth through the decade, with supply constraints likely becoming the main limiting factor rather than demand, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CBRS
Unlock Now

People Also Watch